OPTIMIZATION OF THERAPEUTIC MANAGEMENT IN ACUTE OBSTRUCTIVE BRONCHITIS IN CHILDREN WITH MYOCARDITIS

Respiratory diseases are the most common group of diseases among the child population and occupy the first place in the structure of the general morbidity of children. The relevance of chronic bronchopulmonary processes, disability and mortality remains. The aim of the study is to study the effectiveness of the use of nebulizer inhalation of ipratropium bromide and oral levocarnitine in acute obstructive bronchitis in children with myocarditis. Materials and research methods. Under observation were 100 children aged 1 to 10 years with acute obstructive bronchitis against the background of myocarditis, who received inpatient treatment in pediatric departments and the pediatric intensive care unit of the Samarkand branch of the Republican Scientific Center for Emergency Medical Care, Samarkand Regional Children's Multidisciplinary Medical Center. The patients were divided into 2 groups: Group I (60 patients) - children with acute obstructive bronchitis against the background of myocarditis, Group II - 40 patients - children with acute obstructive bronchitis. Patients with children with acute obstructive bronchitis on the background of myocarditis were divided into 2 subgroups: subgroup Ia of 30 children who received standard therapy and subgroup Ib of 30 children who received nebulizer inhalations of ipratropium bromide and oral levocarnitine in addition to standard therapy.

Hali tarjima qilinmagan